Protect Pharmaceutical Corp

Protect Pharmaceutical Corp

OOTC:PRTT
0.06
USD
+0.00
(-4.80%)
-0.01EPS
789,136.60Market Cap

Total Valuation

USD

As of June 30, 2018, Protect Pharmaceutical Corp carries a market capitalization of 789,136.60, placing it among publicly traded companies globally. Its enterprise value stands at 890,064.60, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap789,136.60
Enterprise Value890,064.60

Share Statistics

As of June 30, 2018, Protect Pharmaceutical Corp has 1.11M shares outstanding.

Shares Outstanding1.11M

Valuation Ratios

These figures are as of June 30, 2018.

PB Ratio-5.21
P/TBV Ratio-5.21
P/FCF Ratio12,482.03
P/OCF Ratio10,960.23

Financial Position

As of June 30, 2018, Protect Pharmaceutical Corp maintains a current ratio of 0.40, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -79.82, indicating conservative leverage, while an interest coverage ratio of -0.05 demonstrates limited ability to service its debt obligations.

Current Ratio0.40
Quick Ratio0.40
Debt / Equity-79.82
Debt / EBITDA-171.15
Interest Coverage-0.05

Financial Efficiency

These figures cover the twelve months ended June 30, 2018. Return on assets (ROA) is negative at -149.83, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 3.00, a quick read on workforce productivity versus industry peers.

Return on Assets (ROA)-149.83
Employee Count3.00

Stock Price Statistics

USD

As of the close on November 12, 2026, Protect Pharmaceutical Corp's stock has declined approximately 69.12% over the past 52 weeks. The 50-day moving average sits at 0.23, while the 200-day moving average is 0.42.

52-Week Price Change-69.12%
50-Day Moving Average0.23
200-Day Moving Average0.42

Income Statement

USD

Over the twelve months ended June 30, 2018, Protect Pharmaceutical Corp generated - - in revenue and converted that into -15,037.00 in net income, yielding earnings per share of -0.01. EBITDA reached -707.00, while operating income came in at -707.00.

Operating Income-707.00
Pretax Income-15,037.00
Net Income-15,037.00
EBITDA-707.00
EBIT-707.00
Earnings Per Share (EPS)-0.01

Balance Sheet

USD

As of June 30, 2018, Protect Pharmaceutical Corp holds 20,072.00 in cash and equivalents against 121,000.00 in total debt, resulting in a net debt position of 100,928.00. Total book value stands at -151,600.00, with working capital of -30,600.00 providing operational flexibility.

Cash & Cash Equivalents20,072.00
Total Debt121,000.00
Net Debt100,928.00
Equity (Book Value)-151,600.00
Book Value Per Share-0.14
Working Capital-30,600.00

Cash Flow

USD

Protect Pharmaceutical Corp produced 72.00 in operating cash flow over the twelve months ended June 30, 2018.

Operating Cash Flow72.00
Free Cash Flow72.00

Dividends & Yields

These figures cover the twelve months ended June 30, 2018. Free cash flow yield stands at 0.01, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -2.53, meaning Protect Pharmaceutical Corp raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-2.53
FCF Yield0.01

Stock Splits

Protect Pharmaceutical Corp's most recent stock split took place on November 4, 2014 with a 1000:1 split ratio.

Last Split Date11/4/2014
Split Ratio1000:1

Scores

As of June 30, 2018, Protect Pharmaceutical Corp has an Altman Z-Score of -663.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-663.39